Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis

被引：0
作者：
Qi Pei
Lu Huang
Jie Huang
Jing-kai Gu
Yun Kuang
Xiao-cong Zuo
Jun-jie Ding
Hong-yi Tan
Cheng-xian Guo
Shi-kun Liu
Guo-ping Yang
机构：
[1] Third Xiangya Hospital,Center of Clinical Pharmacology and Pharmacy Department
[2] Central South University,undefined
[3] Drug Metabolism Research Center of Jilin University,undefined
[4] Children's Hospital of Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
schizophrenia; iloperidone; gene polymorphisms; 10; population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1499 / 1508
页数：9
相关论文
共 50 条
[21]   Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach [J].
Kneller, Lisa Alina ;
Zubiaur, Pablo ;
Koller, Dora ;
Abad-Santos, Francisco ;
Hempel, Georg .
CLINICAL PHARMACOKINETICS, 2021, 60 (12) :1569-1582
[22]   Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone [J].
Bartecek, Richard ;
Jurica, Jan ;
Zrustova, Jana ;
Kasparek, Tomas ;
Pindurova, Eva ;
Zourkova, Alexandra .
NEUROENDOCRINOLOGY LETTERS, 2012, 33 (02) :236-244
[23]   Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients [J].
Yan Fu ;
Chang-he Fan ;
He-huang Deng ;
San-hong Hu ;
De-peng Lv ;
Li-hua Li ;
Jun-jie Wang ;
Xin-qiao Lu .
Acta Pharmacologica Sinica, 2006, 27 :328-332
[24]   Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients [J].
Fu, Y ;
Fan, CH ;
Deng, HH ;
Hu, SH ;
Lv, DP ;
Li, LH ;
Wang, JJ ;
Lu, XQ .
ACTA PHARMACOLOGICA SINICA, 2006, 27 (03) :328-332
[25]   Using population pharmacokinetic analyses of drugs metabolized by CYP2D6 to study the genotype-phenotype translation [J].
Frederiksen, Trine .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (02) :113-123
[26]   Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis [J].
Zuo, Xiao-cong ;
Ng, Chee M. ;
Barrett, Jeffrey S. ;
Luo, Ai-jing ;
Zhang, Bi-kui ;
Deng, Chen-hui ;
Xi, Lan-yan ;
Cheng, Ke ;
Ming, Ying-zi ;
Yang, Guo-ping ;
Pei, Qi ;
Zhu, Li-jun ;
Yuan, Hong ;
Liao, Hai-qiang ;
Ding, Jun-jie ;
Wu, Di ;
Zhou, Ya-nan ;
Jing, Ning-ning ;
Huang, Zhi-jun .
PHARMACOGENETICS AND GENOMICS, 2013, 23 (05) :251-261
[27]   Effect of albumin and CYP2B6 polymorphisms on exposure of efavirenz: A population pharmacokinetic analysis in Chinese HIV-infected adults [J].
Meng, Xian-min ;
Li, Zi-ran ;
Zheng, Xin-yin ;
Liu, Yi-xi ;
Niu, Wan-jie ;
Qiu, Xiao-yan ;
Lu, Hong-zhou .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 167
[28]   Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine [J].
Yenilmez, Ebru Dundar ;
Tamam, Lut ;
Karaytug, Onur ;
Tuli, Abdullah .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2018, 21 (05) :374-380
[29]   ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting [J].
Papazisis, Georgios ;
Goulas, Antonios ;
Sarrigiannidis, Alexios ;
Bargiota, Stavroula ;
Antoniadis, Diomidis ;
Raikos, Nikolaos ;
Basgiouraki, Emmanouela ;
Bozikas, Vasileios P. ;
Garyfallos, Georgios .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2018, 33 (01)
[30]   CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects [J].
Ivanova, S. A. ;
Filipenko, M. L. ;
Vyalova, N. M. ;
Voronina, E. N. ;
Pozhidaev, I. V. ;
Osmanova, D. Z. ;
Ivanov, M. V. ;
Fedorenko, O. Yu. ;
Semke, A. V. ;
Bokhan, N. A. .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 160 (05) :687-690
12345